CIBISATAMAB
UNII ZAM5J1ATF2

Substance Identification & Data

This profile provides standardized clinical and technical data for Cibisatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZAM5J1ATF2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2101242-53-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZAM5J1ATF2

CAS Registry Number

2101242-53-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CIBISATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C120097

National Cancer Institute reference terminology for clinical and research data.

INN ID

10636

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-176

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cibisatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CIBISATAMAB

Common Names & Synonyms

ANTI-CEA/CD3 BISPECIFIC ANTIBODY RO6958688

CEA CD3 TCB

CIBISATAMAB [INN]

CIBISATAMAB [USAN]

CIBISATAMAB [WHO-DD]

HUMANIZED IMMUNOGLOBULIN G1 (IGG1) T-CELL BISPECIFIC (TCB) ANTIBODY TARGETING CARCINOEMBRYONIC ANTIGEN (CEA) AND CD3 EPSILON CHAIN (CD3E) ON T-CELLS

Systematic Nomenclature

IMMUNOGLOBULIN G1, HUMANIZED BISPECIFIC TRIVALENT, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN/HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) BIVALENT .GAMMA.-CHAIN, DISULFIDE WITH ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) .KAPPA.-CHAIN, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN) MONOVALENT .GAMMA.-CHAIN AND ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) .KAPPA.-CHAIN

SYS